Barclays
DERM icon

Barclays’s Journey Medical DERM Stock Holding History

Barclays’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.7K Sell
4,622
-17,899
-79% -$139K ﹤0.01% 4563
2025
Q4 		$174K Buy
22,521
+4,955
+28% +$38.9K ﹤0.01% 4397
2025
Q3 		$125K Sell
17,566
-4,837
-22% -$35.1K ﹤0.01% 4544
2025
Q2 		$161K Buy
+22,403
New +$155K ﹤0.01% 4392

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Barclays's DERM Position: Q1 2026 in Review

Barclays reduced its Journey Medical (DERM) stake by 79% in Q1 2026, selling an estimated $139K and leaving 4,622 shares worth $21.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4563.

Barclays first reported a position in DERM in Q2 2025 and has held it in 4 quarters since. The position peaked at $174K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Barclays held 4,622 shares of Journey Medical worth $21.7K as of Q1 2026.
  • Barclays sold 17,899 Journey Medical shares in Q1 2026, an estimated $139K.
  • Journey Medical made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4563 holding.
  • Barclays first reported a position in Journey Medical in Q2 2025 and has held it in 4 quarters since.
  • Barclays's Journey Medical position peaked at $174K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.